PureTech Health noted that its Founded Entity, Karuna Therapeutics announced the submission of a new drug application, or NDA, to the FDA for KarXT for the treatment of schizophrenia.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PRTC: